Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Patterns of lipid-injectable emulsion use in neonatal intensive care units across the United States: A multi-institution survey

  • Katie A. Huff
  • , Sujir Pritha Nayak
  • , Irfan Ahmad
  • , Robert DiGeronimo
  • , Amy Hair
  • , Jae H. Kim
  • , Troy Markel
  • , Anthony Piazza
  • , Kristina Reber
  • , Jessica Roberts
  • , Jotishna Sharma
  • , Kevin Sullivan
  • , Kaashif A. Ahmad
  • , Toby Yanowitz
  • , Muralidhar H. Premkumar
  • Indiana University Bloomington
  • University of Texas Southwestern Medical Center
  • University of California at Irvine
  • University of Washington
  • Baylor College of Medicine
  • University of Cincinnati
  • Emory University
  • University of Missouri at Kansas City
  • Thomas Jefferson University
  • University of Pittsburgh

Producción científica › revisión exhaustiva

8 Citas (Scopus)

Resumen

Background: Lipid-injectable emulsions (ILEs) are a necessity for neonates dependent on parenteral nutrition (PN). In this manuscript, we describe the patterns of ILE use in neonatal intensive care units (NICUs) in the United States (US). Methods: An electronic survey was sent to 488 NICUs across the US between December 2020 and March 2021. Survey fields included availability and utilization of various ILE in neonates. Results: The response rate was 22% (107 out of 488). Soybean oil ILE (SO-ILE) and soybean oil, medium-chain triglycerides, olive oil, fish oil ILE (SO, MCT, OO, FO-ILE) had similar availability (87% vs 86%, respectively), and SO, MCT, OO, FO-ILE was more commonly used (SO-ILE, 71% vs SO, MCT, OO, FO-ILE, 86%). Fish oil-ILE (FO-ILE) was used by 55% of centers. SO-ILE was most frequently used with PN and needs <4 weeks without cholestasis (79%). The most common reason for SO, MCT, OO, FO-ILE use was cholestasis (71%). ILE minimization was used by 28% of SO-ILE and 22% of SO, MCT, OO, FO-ILE users; 95% of these centers restrict SO, MCT, OO, FO-ILE to doses ≤2 g/kg/day. Twenty-two percent of centers started FO-ILE at direct bilirubin of >5 mg/dl. Conclusion: The results of this survey reveal significant variability in ILE usage across the US. Lipid minimization with SO, MCT, OO, FO-ILE and initiation of FO-ILE for cholestasis at higher bilirubin thresholds are prevalent. Such reports are crucial for a better understanding of ILE use in the NICU and in future ILE development.

Idioma originalEnglish
Páginas (desde-hasta)51-58
Número de páginas8
PublicaciónJournal of Parenteral and Enteral Nutrition
Volumen47
N.º1
DOI
EstadoPublished - ene 2023

Huella

Profundice en los temas de investigación de 'Patterns of lipid-injectable emulsion use in neonatal intensive care units across the United States: A multi-institution survey'. En conjunto forman una huella única.

Citar esto